160 related articles for article (PubMed ID: 7869843)
1. Bosentan antagonizes the effects of endothelin-1 on rat gastric blood flow and mucosal integrity.
Lazaratos S; Nakahara A; Goto K; Fukutomi H
Life Sci; 1995; 56(9):PL195-200. PubMed ID: 7869843
[TBL] [Abstract][Full Text] [Related]
2. Bosentan, a novel synthetic mixed-type endothelin receptor antagonist, attenuates acute gastric mucosal lesions induced by indomethacin and HCl in the rat: role of endogenous endothelin-1.
Matsumaru K; Kashimura H; Hassan M; Nakahara A; Hayashi T; Iwata R; Goto K; Muto H; Tanaka N; Fukutomi H
J Gastroenterol; 1997 Apr; 32(2):164-70. PubMed ID: 9085162
[TBL] [Abstract][Full Text] [Related]
3. The effect of nonsteroidal anti-inflammatory drugs on rat gastric mucosa. The role of endothelin.
Murat N; Gidener S; Koyuncuoglu M; Yilmaz O
Saudi Med J; 2007 Apr; 28(4):612-6. PubMed ID: 17457488
[TBL] [Abstract][Full Text] [Related]
4. Effect of BQ-123 and Ro 47-0203 (bosentan) on endothelin-induced vasoconstriction in the rat skin.
Lawrence E; Brain SD
Eur J Pharmacol; 1994 Jul; 260(1):103-6. PubMed ID: 7957619
[TBL] [Abstract][Full Text] [Related]
5. Anti-ulcerogenic properties of endothelin receptor antagonists in the rat.
Padol I; Huang JQ; Hunt RH
Aliment Pharmacol Ther; 1999 Apr; 13(4):537-44. PubMed ID: 10215740
[TBL] [Abstract][Full Text] [Related]
6. Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1994 Jul; 112(3):823-30. PubMed ID: 7921608
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock.
Krejci V; Hiltebrand LB; Erni D; Sigurdsson GH
Crit Care Med; 2003 Jan; 31(1):203-10. PubMed ID: 12545016
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.
Richard V; Hogie M; Thuillez C
Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056
[TBL] [Abstract][Full Text] [Related]
9. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
10. L-arginine and endogenous nitric oxide protect the gastric mucosa from endothelin-1-induced gastric ulcers in rats.
Lazaratos S; Kashimura H; Nakahara A; Fukutomi H; Osuga T; Goto K
J Gastroenterol; 1995 Oct; 30(5):578-84. PubMed ID: 8574328
[TBL] [Abstract][Full Text] [Related]
11. Gastric mucosal injury induced by local ischemia-reperfusion in rats. Role of endogenous endothelin-1 and free radical.
Hassan M; Kashimura H; Matsumaru K; Nakahara A; Iwata R; Hayashi T; Muto H; Tanaka N; Goto K; Fukutomi H
Dig Dis Sci; 1997 Jul; 42(7):1375-80. PubMed ID: 9246031
[TBL] [Abstract][Full Text] [Related]
12. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
[TBL] [Abstract][Full Text] [Related]
13. Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes.
Stevens EJ; Tomlinson DR
Br J Pharmacol; 1995 May; 115(2):373-9. PubMed ID: 7670740
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
[TBL] [Abstract][Full Text] [Related]
16. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist.
Richard V; Kaeffer N; Hogie M; Tron C; Blanc T; Thuillez C
Br J Pharmacol; 1994 Nov; 113(3):869-76. PubMed ID: 7858879
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.
Weber C; Schmitt R; Birnboeck H; Hopfgartner G; van Marle SP; Peeters PA; Jonkman JH; Jones CR
Clin Pharmacol Ther; 1996 Aug; 60(2):124-37. PubMed ID: 8823230
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease.
Wenzel RR; Fleisch M; Shaw S; Noll G; Kaufmann U; Schmitt R; Jones CR; Clozel M; Meier B; Lüscher TF
Circulation; 1998 Nov; 98(21):2235-40. PubMed ID: 9826308
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelin-1 in repeated electrical stimulation-induced microcirculatory disturbance and mucosal damage in rat stomach.
Fukumura D; Kurose I; Miura S; Serizawa H; Sekizuka E; Nagata H; Tsuchiya M; Ishii H
J Gastroenterol Hepatol; 1996 Mar; 11(3):279-85. PubMed ID: 8742927
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced gastric ulcer is attenuated by cetraxate.
Lazaratos S; Kashimura H; Nakahara A; Fukutomi H; Osuga T; Miyauchi T; Goto K
Life Sci; 1993; 53(7):PL123-8. PubMed ID: 8350665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
